|
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
|
journal
|
February 2019 |
|
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
|
journal
|
June 2020 |
|
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
|
journal
|
May 2006 |
|
An interactive web-based dashboard to track COVID-19 in real time
|
journal
|
May 2020 |
|
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
|
journal
|
March 2020 |
|
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
|
journal
|
February 2022 |
|
Collaboration gets the most out of software
|
journal
|
September 2013 |
|
Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
|
journal
|
April 2006 |
|
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
|
journal
|
November 2020 |
|
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
|
journal
|
May 2020 |
|
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
|
journal
|
April 2020 |
|
The antigenic anatomy of SARS-CoV-2 receptor binding domain
|
journal
|
April 2021 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|
journal
|
August 2017 |
|
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
|
journal
|
August 2020 |
|
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
|
journal
|
February 2022 |
|
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
|
journal
|
December 2020 |
|
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
|
journal
|
December 2020 |
|
Data processing and analysis with the autoPROC toolbox
|
journal
|
March 2011 |
|
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|
journal
|
December 2020 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Influence of protein fold stability on immunogenicity and its implications for vaccine design
|
journal
|
March 2017 |
|
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
|
journal
|
July 2006 |
|
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
|
journal
|
August 2020 |
|
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
|
journal
|
December 2021 |
|
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
|
journal
|
January 2021 |
|
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|
journal
|
February 2020 |
|
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
|
journal
|
May 2020 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
|
journal
|
December 2021 |
|
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|
journal
|
July 2020 |
|
A time- and cost-efficient system for high-level protein production in mammalian cells
|
journal
|
September 2006 |
|
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
|
journal
|
January 2021 |
|
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
|
journal
|
September 2020 |
|
Accurate design of megadalton-scale two-component icosahedral protein complexes
|
journal
|
July 2016 |
|
De novo protein design enables the precise induction of RSV-neutralizing antibodies
|
journal
|
May 2020 |
|
Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability
|
journal
|
July 2016 |
|
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
|
journal
|
October 2020 |
|
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
|
journal
|
April 2021 |
|
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
|
journal
|
May 2021 |
|
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
|
journal
|
September 2021 |
|
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
|
journal
|
February 2004 |
|
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
|
Proof of principle for epitope-focused vaccine design
|
journal
|
February 2014 |
|
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
|
journal
|
April 2020 |
|
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
|
journal
|
July 2020 |
|
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
|
journal
|
December 2020 |
|
XDS
|
journal
|
January 2010 |
|
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
|
journal
|
December 2020 |
|
One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen
|
journal
|
January 2017 |
|
ExPASy: the proteomics server for in-depth protein knowledge and analysis
|
journal
|
July 2003 |
|
How good are my data and what is the resolution?
|
journal
|
June 2013 |
|
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
|
journal
|
August 2020 |
|
Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R
|
journal
|
September 2006 |
|
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
|
journal
|
July 2020 |
|
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
|
journal
|
February 2021 |
|
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
|
journal
|
March 2021 |
|
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
|
journal
|
April 2021 |
|
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
|
journal
|
June 2020 |
|
Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain
|
journal
|
May 2009 |
|
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
|
journal
|
May 2012 |
|
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
|
journal
|
March 2013 |
|
An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
|
journal
|
October 2017 |
|
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
|
journal
|
February 2021 |
|
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
|
journal
|
November 2020 |
|
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
|
journal
|
June 2020 |
|
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
|
journal
|
September 1997 |
|
Human neutralizing antibodies elicited by SARS-CoV-2 infection
|
journal
|
May 2020 |